Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
ZINC96222891 Potential treatment - theoretical effect Experimental Antiviral Jul/31/2020 1 0
ZINC218242102 Potential treatment - theoretical effect Experimental Antiviral Jul/31/2020 1 0
ZINC16429284 Potential treatment - theoretical effect Experimental Antiviral Jul/31/2020 1 0
ZINC1570001158 Potential treatment - theoretical effect Experimental Antiviral Jul/31/2020 1 0
ZINC15275997 Potential treatment - theoretical effect Experimental Antiviral Jul/31/2020 1 0
Zanamivir Potential treatment - theoretical effect Used to treat other disease Antiviral Oct/20/2020 1 0
Z-FA-FMK Potential treatment - pre-clinical evidence Experimental Antiviral Jan/24/2021 1 0
Wogonin Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021 2 0
Withanoside V Potential treatment - theoretical effect Natural product Antiviral Aug/27/2020 1 0
VS12 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/24/2021 1 0